These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18211933

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab.
    Sugimoto Y, Mochizuki H, Miyagi H, Kawamata S, Kiuchi Y.
    Curr Eye Res; 2013 Apr; 38(4):487-96. PubMed ID: 23373847
    [Abstract] [Full Text] [Related]

  • 23. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
    Nonobe NI, Kachi S, Kondo M, Takai Y, Takemoto K, Nakayama A, Hayakawa M, Terasaki H.
    Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
    [Abstract] [Full Text] [Related]

  • 24. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab.
    Kiss C, Michels S, Prager F, Weigert G, Geitzenauer W, Schmidt-Erfurth U.
    Retina; 2006 Oct; 26(8):877-81. PubMed ID: 17031286
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes.
    Schraermeyer U, Julien S.
    Expert Opin Biol Ther; 2013 Feb; 13(2):157-67. PubMed ID: 23190450
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
    Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ.
    Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
    [Abstract] [Full Text] [Related]

  • 33. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.
    Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S.
    Ophthalmology; 2008 Oct; 115(10):1750-5, 1755.e1. PubMed ID: 18708261
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aqueous humor concentration of bevacizumab after subconjunctival injection in rabbit.
    Kim MJ, Han ES, Kim J, Kim TW.
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):49-53. PubMed ID: 20148650
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intracameral bevacizumab for iris rubeosis.
    Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group.
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [Abstract] [Full Text] [Related]

  • 40. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy.
    Oshima Y, Sakaguchi H, Gomi F, Tano Y.
    Am J Ophthalmol; 2006 Jul; 142(1):155-8. PubMed ID: 16815267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.